AmDerma

AmDerma and Oculus Innovative Sciences Enter Into Multi-Country Agreement to Develop and Commercialize Novel Microcyn(R)-Based Drugs for Major Dermatological Conditions
Mon, 06/25/12 - 11:14 pm
AmDerma
Oculus Innovative Sciences
contract
dermatology
AmDerma Pharmaceuticals Exercises Option to License Rights to Oculus Innovative Sciences Microcyn(R)-Based Acne Drug Candidate
Tue, 06/28/11 - 11:23 pm
AmDerma
liscense
Oculus Innovative Sciences
Drug